This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

NP-AU-NA-WCNT-250004 Date of Approval July 2025.

Continue

Go back

 

  • ASYEVE0001=Event Registration
  • ASYEVE0002=Watched General Video
  • ASYEVE0003=Watched Virtual Rep Video
  • ASYEVE0004=Watched Patient Video
  • ASYEVE0005=Watched Expert Video
  • ASYEVE0006=Watched Webcast
  • ASYEVE0007=Downloaded Content-Portal
  • ASYEVE0008=Clicked to App Store
  • ASYEVE0009=Watched Learning Module Video
  • ASYEVE0010=eMail Sent
  • ASYEVE0011=eMail Read
  • ASYEVE0012=eMail Clicked
  • ASYEVE0013=Shared a Link
  • ASYEVE0014=Rep Request
  • ASYEVE0015=Joined health.gsk
  • ASYEVE0016=email Not Sent
  • ASYEVE0017=Email Not Sent
  • ASYEVE0018=Email Not Sent
  • ASYEVE0037=IJSFAID is not available
  • ASYEVE0038=EMAIL ID and IJSFAID is not available
  • ASYEVE0039=The user is opted out
  • ASYEVE0040=Scope IDs are different

Request a contact

National Immunisation Program (NIP) Support

NIP Vaccines Portfolio

GSK currently provide multiple vaccines to the NIP which help combat a variety of potentially life threatening diseases. To find out more about GSK products, please visit the Products section.

Visit Products

LEARN MORE

Our Commitment to the NIP

GSK are currently the primary supplier of childhood vaccines to the National Immunisation Program (NIP) in Australia, helping provide protection against potentially life threatening diseases like polio, measles, diphtheria and tetanus.

Videos

A selection of educational videos covering a range of topics relevant to vaccines management and understanding.
 

Watch Videos

LEARN MORE

Print Materials

Download branded and unbranded materials to improve your understanding of GSKs involvement with the National Immunisation Program, and to assist with vaccines management.

View Materials

LEARN MORE